Home India's Dr Reddy's gets FDA warning letter for three drug plants
 

Keywords :   


India's Dr Reddy's gets FDA warning letter for three drug plants

2015-11-06 07:48:12| Biotech - Topix.net

MUMBAI: Dr Reddy's Laboratories Ltd, India's second-largest drugmaker by sales, received a warning letter from the U.S. Food and Drug Administration over inadequate quality control procedures at three manufacturing plants in India. Dr Reddy's shares fell as much as 12 percent in early trade to their lowest level since July 30. The warning letter was issued by the FDA to Dr Reddy's on Thursday for its Srikakulam, Miryalaguda and Duvvada drug manufacturing plants - all based in southern India.

Tags: three letter drug warning

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
17.05Fewer crackers in Ritz boxes but price remains same
17.05Eastern North Pacific Tropical Weather Outlook
17.05Boeing boss's $33m pay package approved
17.05Heifers and female cows remain hot topic at sale barn
17.05Dutch Boy Paints Introduces Professional Series at Menards
17.05Atlantic Tropical Weather Outlook
17.05RadTech 2024 Sustainability Award Winners are Selected
17.05BYK-Gardner USA Launches New Dispermat Dissolver CV3evo
More »